logo-altasciences

EN - Main navigation

  • Proactive Drug Development
  • Solutions
  • Compare Us
  • Facilities
  • About Us
  • Resource Center
  • Careers
  • News & Events
  • 30th Anniversary Celebration
  • Contact Us
  • Participate in a study
Français
  • Home

Search results

Share this page

  • News

    BioPharma Dive: Pharmaceutical Research on mRNA and CAR T-Cell Therapy in Cancer — Pioneering the Future of Oncology

    Oct 21, 2024

    • Clinical Trials
    • Preclinical Research
  • Blog

    Up Close and Personal with Jason Boehme, Associate Director, Program Management

    Oct 15, 2024

  • ISSUE NO. 40 — Analytical Testing: Accurate and Complete Characterization of Your API to Maximize Bioavailability

    Sep 23, 2024

    • Manufacturing and Analytical Services
  • Event

    The Golden Era of GLP-1 Drugs

    Sep 9, 2024

    Oct 3, 2024

    • Clinical Trials
  • Blog

    Case Study: How to Evaluate Human Abuse Potential (HAP) for CNS Drugs

    Sep 6, 2024

    Altasciences supported a client with HAP studies for the development of a novel analgesic, mirogabalin, currently marked in Japan, Korea, Taiwan, and China.

    • Clinical Trials
  • Scientific Publication

    Case Study—Nanosuspension Formulation to Maximize Potency for Preclinical Studies

    Sep 6, 2024

    • Manufacturing and Analytical Services
    • Preclinical Research
  • Scientific Publication

    Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs

    Jun 20, 2024

    • Clinical Trials
  • Previous page
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • Next page

Sign up for exclusive content

Join our list of 30,000+ VIP members and have access to our exclusive content.

Stay connected

  • linkedin
  • youtube

Footer

    • Solutions

      • Preclinical Services
      • Clinical Services
      • Manufacturing and Analytical Services
      • Bioanalytical Services
      • Research Support Services
      • Development Programs
    • News & Events

      • Altasciences Events
      • Press Releases
      • Altasciences in the News
      • Press Kit
    • Resource Center

      • The Altascientist
      • Webinars/Podcasts
      • Newsletters
      • Scientific Publications
      • Blog
      • Videos
    • Study Types

      • Preclinical
      • Lead Optimization
      • Dose Range Finding​
      • Preclinical Pharmacology
      • Pharmacokinetics/​Pharmacodynamics
      • Cell and Gene Therapy
      • Pivotal Toxicology
      • Safety Pharmacology
      • Immunotoxicology/Immunology
      • Clinical
      • First in Human
      • Proof of Concept
      • Bioavailability/Bioequivalence
      • Pharmacokinetics in Special Populations
      • Human Abuse Potential
      • Driving Simulation
      • Drug-Drug Interaction
      • QT Assessment
      • Renal and Hepatic Impaired
      • Imaging
      • Biologics​/​Biosimilars
    • Therapeutic Areas

      • Cardiology
      • Dermatology
      • Gastroenterology
      • Hematology
      • Immunology
      • Infectious Diseases
      • Metabolism and Endocrinology
      • CNS/Neurology
      • Oncology
      • Ophthalmology
      • Orthopedics
      • Psychiatry
      • Respirology
      • Rheumatology
      • Substance Abuse
      • Urology
      • Women’s Health
    • About us

      • History
      • Our Origins
      • Awards
      • Testimonials
    • Careers

    • Contact Us

    • Locations

    • Stay connected

      • Facebook
      • Youtube

2025 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy

Have a question?

I'd be happy to help.

Captcha is required.